Article
Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis.
Joint bone spine - 1 Dec 2012
Morales-Lara María José, Cañete Juan D, Torres-Moreno Daniel, Hernández María Victoria, Pedrero Francisco, Celis Raquel, García-Simón María Sergia, Conesa-Zamora Pablo
Abstract excerpt
OBJECTIVES: As the role of polymorphisms in death receptors (DRs) such as Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptor 1 (TRAIL-R1) and Tumor Necrosis Factor Receptor 1A (TNF-R1A) on the response to anti-TNF therapy remains unknown, we evaluated the association between TRAILR1 and TNFR1A gene polymorphisms (rs20575/C626G and rs767455/G36A) and the pharmacogenetics of patients with rheumatoid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
